Showing results (121-130 of 276) with videos related to
Sort By:
Pageof 28
Neurochemical Research|November 25, 2023
The Possible Role of Brain-derived Neurotrophic Factor in EpilepsyRaed AlRuwaili, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.Journal of Cellular and Molecular Medicine|June 6, 2024
Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson diseaseMohammed Alrouji, Haydar M Al-Kuraishy, Ali I Al-Gareeb, et al.Journal of Cellular and Molecular Medicine|December 7, 2024
New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: Mechanistic roleNaif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.Current Drug Metabolism|January 31, 2018
Relationship between CNS and Immunology: Correlation with PsychologyGhulam Md Ashraf, Asim Azhar, Qamar Zia, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|November 17, 2022
Bioactive compounds, pharmacological actions and pharmacokinetics of Cupressus sempervirensGaber El-Saber Batiha, John Oluwafemi Teibo, Hazem M Shaheen, et al.Research in Veterinary Science|July 2, 2025
Moniezia benedeni infected Zaraibi (Egyptian Nubian) goats: Insights into serum biochemical changes, redox imbalance, and molecular mechanisms of oxidative-inflammatory cascades mediated intestinal injuryMahmoud Abdelhamid, Ahmed Magdy Selim, Ragab Hassan Mohamed, et al.Metabolic Brain Disease|June 11, 2025
Tirzepatide: a novel therapeutic approach for Alzheimer's diseaseGhadah H Alshehri, Hayder M Al-Kuraishy, Huda Jaber Waheed, et al.Acta Diabetologica|October 7, 2025
Therapeutic potential of copper II oxide in treating diabetic wounds: an emerging approach for enhanced healingSubhasri Bogadi, Md Ekhtiar Uddin, Veera Venkata Satyanarayana Reddy Karri, et al.The Journal of Pharmacology and Experimental Therapeutics|July 17, 2025
Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapyNajlaa Hamed Almohmadi, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.Brain and Behavior|August 12, 2025
Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS PathwaysGhadah H Alshehri, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.Pageof 28